Clinicopathological study on rare primary liver malignant tumor
Huan Yang,Xinglong Zheng,Qianjin Zhang,Wenyan Liu,Xufeng Zhang,Junxi Xiang,Xuemin Liu,Yi Lv
DOI: https://doi.org/10.3969/j.issn.1672-4992.2017.13.016
2017-01-01
Journal of Modern Oncology
Abstract:Objective:To investigate the clinicopathologic characteristics of rare primary liver malignant tumor,improving the accuracy of diagnosis and treatment level.Methods:24 cases of rare primary liver malignant tumor (20 cases underwent surgical resection,4 cases underwent biopsy) which were confirmed by histopathology and immunohistochemistry,were collected in our hospital from Jan.2003 to Dec.2012.A retrospective analysis was made on these cases combined with literature.Results:Rare primary malignant liver tumor accounted for 2.75 ％ (24/874) of all cases of primary liver tumor over the same period,including 13 kinds of pathology:Hepatoblastoma (n =5),neuroendocrine neoplasms (n =4),lymphoma (n =3),cholangiocarcinoma (n =2),malignant neurilemmoma (n =2),malignant perineurioma (n =1),epitheliod hemangioendothelioma (n =1),mucinous epithelioid angiomyolipoma (n =1),pleomorphic sarcoma (n =1),carcinosarcoma (n =1),leiomyosarcoma (n =1),spindle cell carcinoma (n =1),squamous cell carcinoma (n =1).In this group,the ratio of male to female was 2:1 (16:8),with a mean age of 48.90 years old (6 ～74 years old,a median age of 51 years old).The 1 and 5 years postoperative survival rate were 49.0％ and 26.1％.Conclusion:It is difficult to make a clinical diagnosis on rare primary malignant liver tumor.Specimens from surgical resection or biopsy for immune pathology examination are the gold standard for diagnosis.Radical resection and effective chemotherapy or targeting therapy according to guideline are necessary on treatment.